Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05927350
Other study ID # HM20026635
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date June 2024
Est. completion date June 2024

Study information

Verified date May 2024
Source Virginia Commonwealth University
Contact An Pham, MD
Phone 804-628-5880
Email an.pham@vcuhealth.org
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Research has historically excluded the participation of transgender and gender-diverse people. The purpose of this research study is to find out about what goes into a transgender and gender-diverse youth's decision to participate in research. The results of this study will be used to improve access to research for transgender and gender-diverse youth and therefore, improve the representation of transgender and gender-diverse youth as research participants in research.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 250
Est. completion date June 2024
Est. primary completion date June 2024
Accepts healthy volunteers No
Gender All
Age group 15 Years to 21 Years
Eligibility Inclusion Criteria: - Gender identity different then sex assigned at birth - Between the ages 15-21 years Exclusion Criteria: - Gender identity the same as their sex assigned at birth - Younger than 15 years of age, and older than 21 years of age

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Survey
Survey asking about sociodemographics, pediatric research participation, experience with research, gender minority stress and resilience, vaccine hesitancy, medical mistrust, and connectedness to the LGBT community

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Virginia Commonwealth University

Outcome

Type Measure Description Time frame Safety issue
Primary Quantitative Assessment of Pediatric Research Participation in Transgender Youth The outcome will be the responses (agree or disagree) to the different items in the Pediatric Research Participation measure. through study completion, estimated to be 3 months
Primary Qualitative Assessment of Pediatric Research Participation in Transgender Youth The investigators will implement qualitative analysis to explore transgender and gender-diverse youths experiences with research, and barriers and facilitators to participating in research. Specifically, the outcomes will be themes and supporting quotes. through study completion, estimated to be 3 months
See also
  Status Clinical Trial Phase
Completed NCT04036500 - Transgender Estradiol Early Phase 1
Terminated NCT04534881 - Effect of Progesterone on Testosterone Concentrations and Breast Development in Transwomen Phase 2
Recruiting NCT05469204 - Effect of Estrogen Treatment on Drug Metabolism and Transport
Not yet recruiting NCT05337865 - Transgender Observational Performance
Completed NCT04448418 - The Impact of COVID-19 Outbreak on Trans-population's Health in Italy
Active, not recruiting NCT05116293 - Effect of Testosterone Treatment on Drug Metabolism and Transport
Recruiting NCT05166083 - Investigation of the Perceptual and Acoustic Voice in Trans Man
Recruiting NCT04515472 - Effect of Gender Affirming Hormone Therapy on Glucose Metabolism Early Phase 1
Not yet recruiting NCT06177600 - TransHealthGUIDE: Transforming Health for Gender-Diverse Youth N/A
Completed NCT03864913 - Comparing Subcutaneous Testosterone to Intramuscular Testosterone in Gender Affirming Care of Transgender Male Adolescents Early Phase 1
Recruiting NCT05924217 - Gynecology Beyond Gender: Cervical Cancer Screening in Transgender Men in France
Completed NCT05187442 - The Experiences of Erotic and Sexual Risk of Transgender Men: Exploratory Research Design
Completed NCT03120936 - The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community Phase 4
Recruiting NCT04478760 - Trans & Non-binary Reference Intervals While on Hormone Therapy Study